Bellus Health Inc (TSX:BLU)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 29, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bellus Health Inc

< Previous 1 2 Next >

BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders

June 16, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition

May 16, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights

May 12, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Announces Meeting Updates

April 26, 2023

From BELLUS Health Inc.

Via Business Wire

GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

April 18, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation

April 05, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports Year 2022 Financial Results and Business Highlights

March 21, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference

March 01, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Present on the Patient Experience and the Burden of Refractory Chronic Cough at the American Academy of Allergy, Asthma & Immunology Annual Meeting

February 08, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights

November 14, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences

November 10, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual Meeting

October 10, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Present at the H.C. Wainwright Global Investment Conference

September 06, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the European Respiratory Society International Congress 2022

August 22, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights

August 10, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United States

July 18, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States

July 13, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States

July 13, 2022

From BELLUS Health Inc.

Via Business Wire

Bellus Health Announces Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough

July 12, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Participate in the William Blair Biotech Focus Conference

July 05, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Participate in the Jefferies Healthcare Conference

June 01, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights

May 11, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference

May 02, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Participate in Multiple Upcoming Investor Conferences

April 25, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports Year 2021 Financial Results and Business Highlights

February 23, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the United States

December 17, 2021

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States

December 14, 2021

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States

December 13, 2021

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough

December 13, 2021

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights

November 10, 2021

From BELLUS Health Inc.

Via Business Wire

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.